Hydromorphone
Also known as: Dilaudid.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 1 MG/ML | Solution | $0.243 / mL | — | Generic |
| 2 MG | Tablet | $0.165 / unit | — | Generic |
| 2 MG/ML | (unspecified) | $3.24 / mL | — | Generic |
| 2 MG/ML | Vial | $2.77 / mL† | — | Generic |
| 4 MG | Tablet | $0.217 / unit | — | Generic |
| 5 MG/5 ML | Solution | $0.243 / mL | — | Generic |
| 8 MG | Tablet | $0.567 / unit | — | Generic |
| 8 MG | Tablet ER | $6.04 / unit | — | Generic |
| 10 MG/ML | Vial | $2.57 / mL† | — | Generic |
| 12 MG | Tablet ER | $10.01 / unit | — | Generic |
| 16 MG | Tablet ER | $10.97 / unit | — | Generic |
| 50 MG/5 ML | Vial | $2.57 / mL† | — | Generic |
| 500 MG/50 ML | Vial | $2.57 / mL† | — | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. † Package size not curated yet — priced per single unit/mL, not per full pen, inhaler, or vial. Liquids, creams, and sprays are priced per mL or gram; a typical package may be a bottle or tube (size not set yet).
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $6,548,104 gross for Hydromorphone across 196,779 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$13,513,417 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS